PREMARKET ALERT: Cephid (CPHD)

Posted in pre-market 
July 13th, 2009

Cephid (Nasdaq: CPHD) shares are up 9 percent to $9.15 on more than 4,000 premarket shares traded as of 8:30 a.m. Eastern. the molecular-diagnostics company said it has received the FDA’s OK for a new test that the company says can diagnose a bacteria linked to antibiotic-resistant infections, diarrhea and colitis within 45 minutes. – Mike Tarsala

Comments are closed

-->